The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome
暂无分享,去创建一个
K. Butler | K. Butler | F. Mulcahy | S. Clarke | S. Condon | C. M. Healy | S. M. Clarke
[1] P. Husslein. Elective caesarean section versus vaginal delivery , 2001, Archives of Gynecology and Obstetrics.
[2] M. Kalish,et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. , 1999, The Journal of infectious diseases.
[3] C. Sabin,et al. Virological response to protease inhibitor therapy in an HIV clinic cohort. , 1999, AIDS.
[4] B. Hirschel,et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects , 1998, AIDS.
[5] M. Newell. Mechanisms and timing of mother‐to‐child transmission of HIV‐1 , 1998, AIDS.
[6] C. Katlama,et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. , 1997, The Journal of infectious diseases.
[7] R. Gelber,et al. "Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type I with Zidovudine Treatment." , 1994 .
[8] C. Stoll,et al. Genetic and environmental factors in hypospadias. , 1990, Journal of medical genetics.
[9] R. Bertollini,et al. A Joint International Study on the Epidemiology of Hypospadias , 1986, Acta paediatrica Scandinavica. Supplement.